Prescription drug · ANDA
Paliperidone NDC 43975-350
Paliperidone 3 mg/1 · Tablet, Extended release · Oral · ANI Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 43975-350-03 | 4397503500343975035003 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43975-350-03)Marketed from Nov 27, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Paliperidone
- Generic name (nonproprietary)
- paliperidone
- Active ingredients
- Paliperidone — 3 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- ANI Pharmaceuticals, Inc.NDC labeler code 43975
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204452
- Marketing start
- Listing expires
- Identifiers
- Product ID 43975-350_57a9842e-b847-e3c7-e063-6294a90af4fcSPL ID 57a9842e-b847-e3c7-e063-6294a90af4fcSPL set ID bbbaa057-f587-4eb9-a0d2-463dbcd57661RxCUI 672567, 672569, 672571, 866103UNII 838F01T721UPC 0343975352034, 0343975350030, 0343975349034, 0343975351037
- Pharmacologic class
- Atypical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N443975035003followed by a unit qualifier and the quantityPackage 43975-0350-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
1. INDICATIONS AND USAGE Paliperidone is an atypical antipsychotic agent indicated for Treatment of schizophrenia ( 1.1 ) Adults: Efficacy was established in three 6-week trials and one maintenance trial. ( 14.1 ) Adolescents (ages 12-17): Efficacy was established in one 6-week trial. ( 14.1 ) Treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressants. ( 1.2 ) Efficacy was established in two 6-week trials in adult patients. ( 14.2 ) 1.1 Schizophrenia Paliperidone extended-release tablets are indicated for the treatment of schizophrenia [see Clinical Studies (14.1) ]. The efficacy of paliperidone in schizophrenia was established in three …
Excerpt only. Read the full label for complete information.
About NDC 43975-350
- What is NDC 43975-350?
- 43975-350 is the product NDC for Paliperidone, Paliperidone 3 mg/1 tablet, extended release, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Paliperidone.
- What is the active ingredient?
- Paliperidone.
- Who is the labeler?
- ANI Pharmaceuticals, Inc., NDC labeler code 43975. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Paliperidone?
- 64 other product NDCs are listed under this name. See all Paliperidone NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Paliperidone products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Paliperidone | Paliperidone 6 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-1630 | 67046-1630-03 |
| Paliperidone | Paliperidone 1.5 mg/1 | Tablet, Extended releaseOral | Westminster Pharmaceuticals, LLC | 69367-432 | 69367-0432-30 |
| Paliperidone | Paliperidone 3 mg/1 | Tablet, Extended releaseOral | Westminster Pharmaceuticals, LLC | 69367-433 | 69367-0433-30 |
| Paliperidone | Paliperidone 6 mg/1 | Tablet, Extended releaseOral | Westminster Pharmaceuticals, LLC | 69367-434 | 69367-0434-30 |
| Paliperidone | Paliperidone 9 mg/1 | Tablet, Extended releaseOral | Westminster Pharmaceuticals, LLC | 69367-435 | 69367-0435-30 |
| Paliperidone | Paliperidone 1.5 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 72162-2648 | 72162-2648-03 |
| Paliperidone | Paliperidone 3 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 72162-2649 | 72162-2649-03 |
| Paliperidone | Paliperidone 6 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 72162-2650 | 72162-2650-03 |
| Paliperidone | Paliperidone 9 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 72162-2651 | 72162-2651-03 |
| Paliperidone | Paliperidone 1.5 mg/1 | Tablet, Extended releaseOral | Eskayef Pharmaceuticals Limited | 72658-1253 | 72658-1253-0172658-1253-0272658-1253-03 |
Other NDCs under ANDA 204452
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Paliperidone | Paliperidone 1.5 mg/1 | Tablet, Extended releaseOral | ANI Pharmaceuticals, Inc. | 43975-349 |
| Paliperidone | Paliperidone 6 mg/1 | Tablet, Extended releaseOral | ANI Pharmaceuticals, Inc. | 43975-351 |
| Paliperidone | Paliperidone 9 mg/1 | Tablet, Extended releaseOral | ANI Pharmaceuticals, Inc. | 43975-352 |